Some women find one medication suits them better than another in terms of side effect profile, and if fatigue is significantly affecting your quality of life it's worth discussing whether your current medication and dose is the right fit with your SheMed clinician
Finally serious about weight loss
Katsiki N, Ofori-Asenso R, Ferrannini E, Mazidi M (2020) Fixed-dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: a systematic review and meta-analysis
Insurance Coverage: Varies significantly by plan
Author: Shelley Jeon, PharmD Candidate 2025, Northeastern University School of Pharmacy Reviewer: Courtney Cameron, PharmD, BCACP What data are available on weight regain after stopping GLP-1 receptor agonists
For example, GLP-1RAs may modulate the CD36-JNK-AP1 pathway by partially down-regulating prolyl 4-hydroxylase subunit alpha-1 (P4HA1), and then inhibit ROS production mediated by Ang II type I receptor, thereby ameliorating cardiac fibroblast proliferation and myocardial fibrosis [167, 168]